Mount Sinai School of Medicine

New York, New York NY 10029

11 studies enrolling now · 434 studies all time

What they study most

21-hydroxylase Deficiency, ADHD, Abdominal Aortic Aneurysms, Acid Maltase Deficiency Disease, Actinic Keratosis, Acute Kidney Injury, Acute Leukemia, Acute Liver Failure, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Steroid Responsive Dermatoses

Studies at this site

• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma — Recruiting now
• Study of INCA036978 in Participants With Myeloproliferative Neoplasms — Recruiting now
• Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis — Recruiting now
• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP) — Recruiting now
• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF) — Recruiting now
• Cholesterol Lowering and Residual Risk in Diabetes, Type 1 — Recruiting now
• Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Completed
• A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease — Running, not enrolling
• Research Study Investigating How Well NDec Works in People With Sickle Cell Disease — Completed
• Alzheimer's Disease Neuroimaging Initiative 4 — Enrolling by invitation
• Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients — Completed
• Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults — Completed
• A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam) — Running, not enrolling
• Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC) — Paused
• Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma — Completed
• Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients — Stopped early
• A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. — Running, not enrolling
• A Communication Tool to Assist Older Adults Facing Dialysis Choices — Completed
• EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy — Completed
• EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA — Completed
• Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease — Completed
• Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease — Completed
• Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease — Completed
• Alzheimer's Disease Neuroimaging Initiative 3 — Completed
• Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis — Completed
• Congenital Heart Disease GEnetic NEtwork Study (CHD GENES) — Running, not enrolling
• App-Based Certified Diabetes Education Therapy (AB-CDE) — Starting soon
• Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan — Enrolling by invitation
• Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2 — Completed
• Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dysglycemia — Completed
• Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205) — Stopped early
• Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients — Stopped early
• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer — Completed
• To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) — Stopped early
• Memory Improvement Through Nicotine Dosing (MIND) Study — Completed
• A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease — Running, not enrolling
• Alzheimer's Plasma Extension — Running, not enrolling
• Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System — Completed
• Obstructive Sleep Apnea in World Trade Center Responders — Completed
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease — Completed
• A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery — Stopped early
• LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) — Completed
• A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp — Completed
• Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer — Completed
• A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis — Completed